AI in Drug and Medical Device Development – Perspectives on Research Ethics

About this session

Plenary 2.

While the foundational principles of modern-day bioethics are well-established, innovative technologies like artificial intelligence have the potential to challenge some of these norms and how we think about human research protection. This talk will explore the use of AI in the regulated environment of drug and medical device development and suggest an approach that (1) emphasizes existing principles and guidelines and (2) advocates for discipline in creating new ethical frameworks. Examples will be shared that elucidate this approach.

Speaker

• KC

  Karla G. Childers

  Head, Bioethics-based Science & Technology Policy, Office of the Chief Medical Officer · Johnson & Johnson

  Speaker